Fauci adviser David Morens indicted for concealing emails, avoiding records requests
Stat News • 4/28/2026
Summary
David Morens, an adviser to Fauci, has been indicted for concealing emails and avoiding records requests. The charges are linked to Congressional probes concerning the origins of the virus that causes Covid-19.
Advertisement
Lindy Score Breakdown (V4.2)
1h
Age
1
Sources
from cluster
3
Hours Since Seen
Final Score12/100
CategoryAntiLindy
StatusActive
Recency Multiplier96% (0.5^3/48)
Hero EligibleYes
Score BreakdownRisk 70
Source Reputation: Low-trust source (4/20 pts)
Consensus: Single source - no independent confirmation yet
Age: Breaking news - too recent to assess longevity
Stories gain Lindy status through source reputation, network consensus, and time survival.
Breaking Similar stories
STAT+: Google’s clinical director on AI challenges
Stat News • Today
STAT+: Erasca touts strong, though preliminary, results in trial of pancreatic and lung cancer therapy
Stat News • 1 day ago
STAT+: Supreme Court to hear case about ‘skinny labeling’ and generic access
Stat News • Today
STAT+: Boehringer’s obesity drug shows 16.6% weight loss; more data needed
Stat News • Today
Opinion: FDA commissioner: ‘Smarter,’ real-time clinical trials could transform drug development
Stat News • Today
STAT+: Intellia says CRISPR-based treatment for rare disease reduced swelling attacks in pivotal trial
Stat News • 1 day ago
STAT+: Eli Lilly enlists AI startup for next-generation gene editors
Stat News • Today
STAT+: A giant question looms over GOP’s new Medicaid work requirements
Stat News • Today
Supreme Court grapples with multibillion-dollar wave of lawsuits over Roundup cancer claims
Stat News • 1 day ago
NIH-funded research lags in reporting sex differences, new study finds
Stat News • 1 day ago
Anti-Lindy Similar stories
STAT+: Pharmalittle: We’re reading about TrumpRx expectations, a high-dose version of Wegovy, and more
Stat News • 1+ months
STAT+: Pharmalittle: We’re reading about an FDA plan for ultra-rare drugs, Novo cutting GLP-1 drug prices, and more
Stat News • 2+ months
STAT+: Pharmalot: We’re reading about a lack of FDA adcomms, FDA loosening biosimilar rules, and more
Stat News • 1+ months
STAT+: Pharmalittle: We’re reading about an FDA OK for a rare disease drug, a grilling of the PTO chief, and more
Stat News • 1+ months
STAT+: FDA panel will meet to discuss allowing broader access to certain peptides
Stat News • 1 week ago
STAT+: Pharmalittle: We’re reading about telehealth prescribers, a Lilly push against compounding, and more
Stat News • 1+ months
STAT+: Pharmalittle: We’re reading about top pharma lobbyist stepping down, genes and GLP-1 drugs, and more
Stat News • 2 weeks ago
STAT+: Trump budget’s ‘America First’ drug policy proposals
Stat News • 3 weeks ago
STAT+: Pharmalittle: We’re reading about cheap telehealth visits, pharma withholding meds in Europe, and more
Stat News • 5 days ago
STAT+: Pharmalittle: We’re reading about Trump and drug prices, biotechs pushing back, and more
Stat News • 1+ months